万邦医药:8月21日召开董事会会议

Group 1 - The company Wanbang Medical (SZ 301520, closing price: 45.83 yuan) announced on August 21 that its third board meeting for 2025 was held on the same day to discuss the appointment of senior management personnel [2] - For the year 2024, the company's revenue composition is entirely from the CRO (Contract Research Organization) industry, accounting for 100.0% [2]